Jupiter Life Line Hospitals cash flow

Latest FY26

Cash from operations: ₹268cr+5.7% on FY25
Capital spending: ₹502cr+56.5% on FY25
Free cash flow: −₹234cr−₹67.4 cr in FY25
Cash from financing: ₹136cr−54.6% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023

Adjustments to reconcile profit — non-cash items
	—	87.6	57.0	42.4	38.6
	—	0.0	2.9	0.0	—
	—	32.7	10.6	26.3	—
	—	−29.4	−19.8	−19.4	−3.1
	—	−0.0	−0.0	−0.0	—
	—	1.9	−1.9	0.0	—
	—	2.0	1.4	0.4	—
	—	0.2	−4.5	0.0	—
Changes in working capital
	—	−11.9	−2.8	−2.3	—
	—	−34.4	1.9	−13.7	—
	—	0.0	12.0	0.0	—
	—	0.0	4.2	−51.5	—
	—	0.0	0.0	−3.5	—
	—	−6.5	0.0	0.0	—
	—	26.8	7.4	−8.5	—
	—	6.5	0.0	0.0	—
	—	−1.9	0.0	−1.3	—
	—	0.0	−0.8	0.0	—
	—	−13.2	0.0	0.0	—
	—	5.9	0.0	0.0	—
Cash from operating activities
	249	265	258	195	129
	—	66.2	63.0	−31.2	—
	—	332	321	164	150
	—	63.9	67.4	49.7	—
	—	268	253	115	—
Cash from investing activities
	—	502	321	85.3	77.2
	—	0.0	0.4	0.1	0.5
	—	0.3	0.0	0.0	—
	—	0.0	0.0	25.5	—
	—	0.0	88.8	9.9	—
	—	−5.9	0.0	0.0	—
	—	0.0	3.1	1.3	—
	—	0.0	0.0	0.0	—
	—	23.5	19.8	23.5	—
	—	30.2	0.0	0.0	—
	—	−442	−209	−75.9	—
Cash from financing activities
	—	0.0	0.0	633	—
	—	186	326	83.9	—
	—	3.3	0.0	556	—
	—	16.2	10.9	0.0	—
	—	23.5	7.6	26.3	42.3
	—	6.6	6.6	5.7	5.1
	—	136	301	128	—
	—	−37.8	345	167	31.1
	—	−37.8	345	167	—
	—	54.8	—	301	—
Reference items
	359	343	297	238	201
	22.1%	22.9%	23.5%	22.3%	22.6%
	−234	−234	−67.4	29.2	—
	—	−74.9	251	—	—
	−₹35.71	−₹35.71	−₹10.28	₹4.46	—
	—	1.34×	1.31×	0.65×	—
	—	63.9	67.4	49.7	—
	—	23.5	7.6	26.3	42.3

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

JLHL₹256.75

Jupiter Life Line Hospitals Ltd.

· Pharma & Health

₹ CrorePeersAPOLLOHOSP MAXHEALTH KIMS HCG MARKSANS METROPOLIS PARKHOSPS CORONAMcap ₹1,683 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	38.6	42.4	57.0	87.6	—
+ Impairment Loss / (Reversal)	—	0.0	2.9	0.0	—
+ Finance Costs	—	26.3	10.6	32.7	—
+ Interest Income	-3.1	-19.4	-19.8	-29.4	—
+ Dividend Income	—	-0.0	-0.0	-0.0	—
+ Fair Value (Gains) / Losses	—	0.0	-1.9	1.9	—
+ Other Non-cash Items	—	0.4	1.4	2.0	—
+ Other — Cash Effects are Investing / Financing	—	0.0	-4.5	0.2	—
Changes in Working Capital
+ Inventories	—	-2.3	-2.8	-11.9	—
+ Trade Receivables — Current	—	-13.7	1.9	-34.4	—
+ Trade Receivables — Non-current	—	0.0	12.0	0.0	—
+ Other Financial Assets — Non-current	—	-51.5	4.2	0.0	—
+ Other Current Assets	—	-3.5	0.0	0.0	—
+ Other Non-current Assets	—	0.0	0.0	-6.5	—
+ Trade Payables — Current	—	-8.5	7.4	26.8	—
+ Other Financial Liabilities — Current	—	0.0	0.0	6.5	—
+ Other Current Liabilities	—	-1.3	0.0	-1.9	—
+ Other Non-current Liabilities	—	0.0	-0.8	0.0	—
+ Provisions — Current	—	0.0	0.0	-13.2	—
+ Provisions — Non-current	—	0.0	0.0	5.9	—
Cash from Operating Activities
Profit Before Tax (per I/S)	128.7	195.4	257.7	265.3	248.6
+ Total Adjustments (incl. Working Capital)	—	-31.2	63.0	66.2	—
Cash from Operations (pre-tax)	150.5	164.2	320.7	331.6	—
+ Income Taxes Paid	—	49.7	67.4	63.9	—
Cash from Operating Activities	—	114.5	253.3	267.7	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	77.2	85.3	320.7	501.8	—
+ Disp of Fixed Assets	0.5	0.1	0.4	0.0	—
+ Disp of Investment Property	—	0.0	0.0	0.3	—
+ Acq of Other Long-term Assets	—	25.5	0.0	0.0	—
+ Disp of Other Long-term Assets	—	9.9	88.8	0.0	—
+ Investment in Partnership Firms / LLPs	—	0.0	0.0	-5.9	—
+ Share of Profits — Partnership Firms / LLPs	—	1.3	3.1	0.0	—
+ Dividends Received — Investing	—	0.0	0.0	0.0	—
+ Interest Received — Investing	—	23.5	19.8	23.5	—
+ Other Inflows / (Outflows) — Investing	—	0.0	0.0	30.2	—
Cash from Investing Activities	—	-75.9	-208.6	-441.9	—
Cash from Financing Activities
+ Proceeds from Issue of Shares	—	632.6	0.0	0.0	—
+ Proceeds from Borrowings	—	83.9	325.7	186.0	—
+ Repayment of Borrowings	—	556.4	0.0	3.3	—
+ Payment of Lease Liabilities	—	0.0	10.9	16.2	—
+ Interest Paid	42.3	26.3	7.6	23.5	—
+ Dividends Paid	5.1	5.7	6.6	6.6	—
Cash from Financing Activities	—	128.2	300.6	136.5	—
Net Changes in Cash (pre-FX)	31.1	166.8	345.3	-37.8	—
Net Changes in Cash	—	166.8	345.3	-37.8	—
Closing Cash	—	301.3	—	54.8	—
Reference Items
EBITDA	201.3	238.2	296.6	343.3	358.7
EBITDA Margin %	22.56	22.27	23.51	22.89	22.13
Free Cash Flow (CFO − Capex)	—	29.2	-67.4	-234.1	-234.1
Free Cash Flow to Equity	—	—	250.7	-74.9	—
Free Cash Flow per Basic Share	—	4.46	-10.28	-35.71	-35.71
Cash Flow to Net Income	—	0.65	1.31	1.34	—
Cash Paid for Taxes	—	49.7	67.4	63.9	—
Cash Paid for Interest	42.3	26.3	7.6	23.5	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.